Results 81 to 90 of about 3,890,295 (331)

The systemic-level repercussions of cancer-associated inflammation mediators produced in the tumor microenvironment. [PDF]

Front Endocrinol (Lausanne), 2022
Aguilar-Cazares D, Chavez-Dominguez R, Marroquin-Muciño M, Perez-Medina M, Benito-Lopez JJ, Camarena A, Rumbo-Nava U, Lopez-Gonzalez JS.   +7 more
europepmc   +1 more source

MEDIATORS OF INFLAMMATION IN LEUKOCYTE LYSOSOMES [PDF]

, 1965
Aaron Janoff, Sonja Schaefer, Joan Scherer, Michael A. Bean   +3 more
openalex   +1 more source

Obesity and inflammation: the linking mechanism and the complications

Archives of medical science : AMS, 2016
Obesity is the accumulation of abnormal or excessive fat that may interfere with the maintenance of an optimal state of health. The excess of macronutrients in the adipose tissues stimulates them to release inflammatory mediators such as tumor necrosis ...
Mohammed S. Ellulu, I. Patimah, H. Khaza’ai, A. Rahmat, Y. Abed   +4 more
semanticscholar   +1 more source

Surfaceome: a new era in the discovery of immune evasion mechanisms of circulating tumor cells

Molecular Oncology, EarlyView.
In the era of immunotherapies, many patients either do not respond or eventually develop resistance. We propose to pave the way for proteomic analysis of surface‐expressed proteins called surfaceome, of circulating tumor cells. This approach seeks to identify immune evasion mechanisms and discover potential therapeutic targets. Circulating tumor cells (
Doryan Masmoudi, Jérome Vialaret, Christophe Hirtz, Catherine Alix‐Panabières   +3 more
wiley   +1 more source

Retracted: Activation of CD137 Signaling Enhances Vascular Calcification through c-Jun N-Terminal Kinase-Dependent Disruption of Autophagic Flux

Mediators of Inflammation, 2022
Mediators of Inflammation
doaj   +1 more source

In Vitro Induction of Eryptosis by Uremic Toxins and Inflammation Mediators in Healthy Red Blood Cells. [PDF]

J Clin Med, 2022
Virzì GM, Mattiotti M, Clementi A, Milan Manani S, Battaglia GG, Ronco C, Zanella M.   +6 more
europepmc   +1 more source

COMPLEMENT AS A MEDIATOR OF INFLAMMATION [PDF]

, 1963
Oscar D. Ratnoff, Irwin H. Lepow
openalex   +1 more source

Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients

Molecular Oncology, EarlyView.
Small cell lung cancer (SCLC) is an aggressive form of lung cancer that spreads rapidly to secondary sites such as the brain and liver. Cancer cells circulating in the blood, “circulating tumor cells” (CTCs), have demonstrated prognostic value in SCLC, and evaluating biomarkers on CTCs could guide treatment decisions such as for PARP inhibitors ...
Prajwol Shrestha, Steven Kao, Veronica K. Cheung, Wendy A. Cooper, Nico van Zandwijk, John E. J. Rasko, Dannel Yeo   +6 more
wiley   +1 more source

Novel Resolution Mediators of Severe Systemic Inflammation

ImmunoTargets and Therapy, 2020
Verena Gudernatsch, Sylwia Anna Stefańczyk, Valbona Mirakaj Molecular Intensive Care Medicine, Department of Anesthesiology and Intensive Care Medicine, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen ...
Gudernatsch V, Stefańczyk SA, Mirakaj V
doaj  

Association between Plasma Leptin Level and Systemic Inflammatory Markers in Patients with Aggressive Periodontitis

Chinese Medical Journal, 2015
Background: Increasing evidence supports an association between periodontitis and systemic diseases. Leptin is involved both in the energy metabolism and inflammatory processes and is suggested to be a link between periodontal infection and systemic ...
Dong Shi, Yun-Yu Liu, Wei Li, Xin Zhang, Xiao-Jun Sun, Li Xu, Li Zhang, Zhi-Bin Chen, Huan-Xin Meng   +8 more
doaj   +1 more source